Vemurafenib and Cobimetinib Combination in BRAF Mutated Melanoma With Brain Metastasis
Phase 2
Completed
- Conditions
- Malignant Melanoma
- Interventions
- First Posted Date
- 2015-09-01
- Last Posted Date
- 2020-01-27
- Lead Sponsor
- Center Eugene Marquis
- Target Recruit Count
- 43
- Registration Number
- NCT02537600
- Locations
- 🇫🇷
CHU de Bordeaux, Bordeaux, France
🇫🇷CHU Caen - Hôpital Clémenceau, Caen, France
🇫🇷CHU Ambroise Paré, Boulogne, France
Positron Emission Tomography (PET) During Radio-chemotherapy to Treat Otorhinolaryngological Cancer
Not Applicable
Completed
- Conditions
- Malignant Neoplasm of Head and NeckLocally Advanced Malignant Neoplasm
- Interventions
- Device: Positron emission tomographyRadiation: radiochemotherapy
- First Posted Date
- 2015-06-12
- Last Posted Date
- 2021-07-27
- Lead Sponsor
- Center Eugene Marquis
- Target Recruit Count
- 130
- Registration Number
- NCT02469922
- Locations
- 🇫🇷
Centre jean Bernard - Rue Victor Hugo, Le Mans, France
🇫🇷CHU Brest, Brest, France
🇫🇷Hôpital du Scorff, Lorient, France
Interest of Functional MRI (Magnetic Resonance Imagery) (in Patients Suffering From Hepatocellular Carcinoma and Treated With Yttrium
Not Applicable
Completed
- Conditions
- Hepatocellular Carcinoma
- Interventions
- Other: Additional RMIs
- First Posted Date
- 2013-12-06
- Last Posted Date
- 2017-11-22
- Lead Sponsor
- Center Eugene Marquis
- Target Recruit Count
- 25
- Registration Number
- NCT02003339
- Locations
- 🇫🇷
Centre Eugène Marquis, Rennes, France
Efficacy Study of Intra-hepatic Administration of Therasphere® in Association With Intravenous Chemotherapy to Treat Cholangiocarcinoma
Phase 2
Completed
- Conditions
- Cholangiocarcinoma
- Interventions
- Radiation: Therasphere® in association with Gemcitabine and Cisplatin
- First Posted Date
- 2013-07-30
- Last Posted Date
- 2018-05-11
- Lead Sponsor
- Center Eugene Marquis
- Target Recruit Count
- 41
- Registration Number
- NCT01912053
- Locations
- 🇫🇷
Hôpital saint-Eloi, Montpellier, France
🇫🇷Hôpital Henri Mondor, Créteil, France
🇫🇷CHU- Hotel Dieu, Nantes, France
Adaptative Radiotherapy to Decrease Xerostomia in Oropharynx Carcinoma
Phase 3
Completed
- Conditions
- Oropharynx Cancer
- Interventions
- Radiation: adaptative radiotherapy
- First Posted Date
- 2013-06-11
- Last Posted Date
- 2021-07-27
- Lead Sponsor
- Center Eugene Marquis
- Target Recruit Count
- 132
- Registration Number
- NCT01874587
- Locations
- 🇫🇷
Clinique Claude Bernard, Albi, France
🇫🇷Clinique Pasteur - Saint Esprit, Brest, France
🇫🇷CRLCC Oscar Lambret, Lille, France
Search for a Link Between Response to Treatment and Circulating Leucocytes in High Grade Glioma Patients
- First Posted Date
- 2013-04-22
- Last Posted Date
- 2017-03-01
- Lead Sponsor
- Center Eugene Marquis
- Target Recruit Count
- 30
- Registration Number
- NCT01836536
- Locations
- 🇫🇷
Center Eugene Marquis, Rennes, France
🇫🇷Hôpital Avicenne, Bobigny, France
Comparison of Different Methods to Test MGMT Status in Glioblastoma Patients
- First Posted Date
- 2011-05-02
- Last Posted Date
- 2016-01-29
- Lead Sponsor
- Center Eugene Marquis
- Target Recruit Count
- 300
- Registration Number
- NCT01345370
- Locations
- 🇫🇷
CHU de Bordeaux, Bordeaux, Aquitaine, France
🇫🇷Center Eugene Marquis, Rennes, Brittany, France
🇫🇷CHU de Poitiers, Poitiers, Poitou-Charentes, France
188RE-SSS Lipiodol to Treat HepatoCellular Carcinomas
Phase 1
Completed
- Conditions
- Hepatocellular Carcinomas
- Interventions
- Drug: 188Re-SSS Lipiodol
- First Posted Date
- 2010-05-19
- Last Posted Date
- 2021-08-02
- Lead Sponsor
- Center Eugene Marquis
- Target Recruit Count
- 16
- Registration Number
- NCT01126463
- Locations
- 🇫🇷
Centre Eugene Marquis, Rennes, France
© Copyright 2025. All Rights Reserved by MedPath